Original Article

You have full text access to this OnlineOpen article

Mapping of human autoantibody binding sites on the calcium-sensing receptor

  1. E Helen Kemp1,*,
  2. Nikos G Gavalas1,
  3. Samia Akhtar1,
  4. Kai JE Krohn2,
  5. J Carl Pallais3,
  6. Edward M Brown4,
  7. Philip F Watson1,
  8. Anthony P Weetman1

Article first published online: 14 DEC 2009

DOI: 10.1359/jbmr.090703

Issue

Journal of Bone and Mineral Research

Journal of Bone and Mineral Research

Volume 25, Issue 1, pages 132–140, January 2010

Additional Information

How to Cite

Kemp, E. H., Gavalas, N. G., Akhtar, S., Krohn, K. J., Pallais, J. C., Brown, E. M., Watson, P. F. and Weetman, A. P. (2010), Mapping of human autoantibody binding sites on the calcium-sensing receptor. J Bone Miner Res, 25: 132–140. doi: 10.1359/jbmr.090703

Author Information

  1. 1

    Department of Human Metabolism, School of Medicine, University of Sheffield, Sheffield S10 2JF, United Kingdom

  2. 2

    Department of Pathology, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Tampere 33101, Finland

  3. 3

    Endocrine Unit, Massachusetts General Hospital, Boston, MA, USA

  4. 4

    Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

*Department of Human Metabolism, School of Medicine, University of Sheffield, Royal Hallamshire Hospital, Glossop Road, Sheffield, S10 2JF, United Kingdom.

Publication History

  1. Issue published online: 20 JAN 2010
  2. Article first published online: 14 DEC 2009
  3. Manuscript Accepted: 1 JUL 2009
  4. Manuscript Revised: 27 MAY 2009
  5. Manuscript Received: 18 FEB 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (121K)

References

  • 1
    Bringhurst FR, Demay MB, Kronenberg HM. Hormones and disorders of mineral metabolism. In: LarsenPR, KronenbergHM, MelmedS, PolonskyKS, eds. Williams Text Book of Endocrinology. 10th ed. Philadelphia: Saunders, 2003: 1303–1371.
  • 2
    Brown EM, Gamba G, Riccardi D, et al. Cloning and characterisation of an extracellular Ca2+-sensing receptor from bovine parathyroid. Nature. 1993; 366: 575–580.
  • 3
    Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab. 2006; 91: 2843–2850.
  • 4
    Nagamine K, Peterson P, Scott HS, et al. Positional cloning of the APECED gene. Nat Genet. 1997; 17: 393–398.
  • 5
    The Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet. 1997; 17: 399–403.
  • 6
    Neufeld M, Maclaren N, Blizzard R. Autoimmune polyglandular syndromes. Pediatr Ann. 1980; 9: 154–162.
  • 7
    Uibo R, Aavik E, Peterson P, et al. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J Clin Endocrinol Metab. 1994; 78: 323–328.
  • 8
    Winqvist O, Karlsson FA, Kampe O. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet. 1992; 339: 1559–1562.
  • 9
    Krohn K, Uibo R, Aavik E, Peterson P, Savilahti K. Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17α-hydroxylase. Lancet. 1992; 339: 770–773.
  • 10
    Tuomi T, Bjorses P, Falorni A, et al. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 1996; 81: 1488–1494.
  • 11
    Gylling M, Tuomi T, Bjorses P, et al. β-Cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab. 2000; 85: 4434–4440.
  • 12
    Posillico JT, Wortsman J, Srikanta S, Eisenbarth GS, Mallette LE, Brown EM. Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells. J Bone Miner Res. 1986; 1: 475–483.
    Direct Link:
  • 13
    Brandi ML, Aurbach GD, Fattorossi A, Quarto R, Marx SJ, Fitzpatrick LA. Antibodies to bovine parathyroid cells in autoimmune hypoparathyroidism. Proc Natl Acad Sci USA. 1986; 83: 8366–8369.
  • 14
    Li Y, Song YH, Rais N, et al. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 1996; 97: 910–914.
  • 15
    Mayer A, Ploix C, Orgiazzi J, et al. Calcium-sensing receptor autoantibodies are relevant markers of acquired hypoparathyroidism. J Clin Endocrinol Metab. 2004; 89: 4484–4488.
  • 16
    Gavalas NG, Kemp EH, Krohn KJE, Brown EM, Watson PF, Weetman AP. The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab. 2007; 92: 2107–2114.
  • 17
    Goswami R, Brown EM, Kochupillai N, et al. Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism. Eur J Endocrinol. 2004; 150: 9–18.
  • 18
    Kifor O, McElduff A, Leboff MS, et al. Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism. J Clin Endocrinol Metab. 2004; 89: 548–556.
  • 19
    Kifor O, Moore FD, Delaney M, et al. A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor. J Clin Endocrinol Metab. 2003; 88: 60–72.
  • 20
    Pallais JC, Kifor O, Chen Y-B, Slovik D, Brown EM. Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor. N Eng J Med 2004; 351: 362–369.
  • 21
    Makita N, Sato J, Manaka K, et al. An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations. Proc Natl Acad Sci USA. 2007; 104: 5443–5448.
  • 22
    Barbas CF, Kang AS, Lerner RA, Benkovic SJ. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci USA. 1991; 88: 7978–7982.
  • 23
    Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
  • 24
    Kemp EH, Waterman EA, Hawes BE, et al. The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo. J Clin Invest. 2002; 109: 923–930.
  • 25
    Dromey JA, Weenink SM, Peters GH, et al. Mapping of epitopes for autoantibodies to the type 1 diabetes autoantigen IA-2 by peptide phage display and molecular modelling: overlap of antibody and T cell determinants. J Immunol 2004; 172: 4084–4090.
  • 26
    Myers MA, Davies JM, Tong JC, et al. Conformational epitopes on the diabetes autoantigen GAD65 identified by peptide phage display and molecular modeling. J Immunol 2000; 165: 3830–3838.
  • 27
    Al-Bukhari TA, Radford PM, Bouras G, et al. Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65-kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis. Clin Exp Immunol. 2002; 130: 131–139.
    Direct Link:
  • 28
    Hu J, Spiegel AM. Structure and function of the human calcium-sensing receptor: insights from natural and engineered mutations and allosteric modulators. J Cell Mol Med. 2007; 11: 908–922.
    Direct Link:
  • 29
    Reyes-Cruz G, Hu J, Goldsmith PK, Steinbach PJ, Spiegel AM. Human Ca2+ receptor extracellular domain: analysis of function of lobe 1 loop deletion mutants. J Biol Chem. 2001; 276: 32145–32151.
  • 30
    Silve C, Petrel C, Leroy C, et al. Delineating a Ca2+-binding pocket within the venus flytrap module of the human calcium-sensing receptor. J Biol Chem 2005; 280: 37917–37923.
  • 31
    Huang Y, Zhou Y, Yang W, et al. Identification and dissection of Ca2+-binding sites in the extracellular domain of Ca2+-sensing receptor. J Biol Chem. 2007; 282: 19000–19010.
  • 32
    Zhang Z, Qiu W, Quinn SJ, Conigrave AD, Brown EM, Bai M. Three adjacent serines in the extracellular domains of the CaR are required for L-amino acid-mediated potentiation of receptor function. J Biol Chem. 2002; 277: 33727–33735.
  • 33
    Syren K, Lindsay L, Stoehrer B, et al. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase. J Immunol. 1996; 157: 5208–5214.
  • 34
    Hu J, Reyes-Cruz G, Goldsmith PK, Gantt NM, Miller JL, Spiegel AM. Functional effects of monoclonal antibodies to the purified amino-terminal extracellular domain of the human Ca2+ receptor. J Bone Miner Res. 2007; 22: 601–608.
    Direct Link:
View Full Article (HTML) Get PDF (121K)